BRK-B vs MFIN
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
MFIN presents a classic deep-value opportunity, trading significantly below its Graham Number ($26.86) and Intrinsic Value ($52.22). While the Piotroski F-Score of 4/9 indicates only stable financial health and the Debt/Equity ratio is high at 4.73, the company demonstrates strong profitability and a consistent track record of earnings beats. The extreme disconnect between the current price ($9.41) and fundamental value metrics suggests a significant margin of safety, provided the high leverage is managed. Technicals remain bearish, but the fundamental growth and valuation profile are compelling.
Compare Another Pair
Related Comparisons
BRK-B vs MFIN: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and Medallion Financial Corp. (MFIN) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.